McFadden v. United States
Supreme Court of the United States
Argued April 21, 2015
Decided June 18, 2015
Full case nameStephen Dominick McFadden, Petitioner v. United States
Docket no.14-378
Citations576 U.S. 186 (more)
135 S. Ct. 2298; 192 L. Ed. 2d 260
ArgumentOral argument
Opinion announcementOpinion announcement
Case history
PriorUnited States v. McFadden, 15 F. Supp. 3d 668 (W.D. Va. 2013); affirmed, 753 F.3d 432 (4th Cir. 2014); cert. granted, 135 S. Ct. 2298 (2015).
Holding
Under §841(a)(1) of the Controlled Substances Act, the government must prove the defendant knew he was dealing with a controlled substance when it is an analogue. United States Court of Appeals for the Fourth Circuit vacated and remanded.
Court membership
Chief Justice
John Roberts
Associate Justices
Antonin Scalia · Anthony Kennedy
Clarence Thomas · Ruth Bader Ginsburg
Stephen Breyer · Samuel Alito
Sonia Sotomayor · Elena Kagan
Case opinions
MajorityThomas, joined by Scalia, Kennedy, Ginsburg, Breyer, Alito, Sotomayor, Kagan
ConcurrenceRoberts (in part)
Laws applied
Controlled Substances Act
Federal Analogue Act

McFadden v. United States, 576 U.S. 186 (2015), was a United States Supreme Court case in which the Court held that section 841 of the Controlled Substances Act requires the government to prove that to be in criminal violation, a defendant must be aware that an analogue defined by the Controlled Substance Analogue Enforcement Act with which he was dealing was a controlled substance.

Background

Controlled substances law

The Controlled Substances Act regulates the manufacture, importation, possession, and distribution of certain substances determined in part by the original legislation and in part by the DEA and FDA. Under §841(a)(1), the Act makes it "unlawful for any person knowingly...to distribute...a controlled substance."[1]

The Controlled Substance Analogue Enforcement Act of 1986 extends the provisions for Schedule I controlled substances to all "controlled substance analogues" of those substances when intended for human consumption, instructing courts to treat them as the same.[2]

Trial of McFadden

In 2012, Stephen McFadden was indicted in the U.S. District Court for the Western District of Virginia on one count of conspiracy to distribute and eight counts of distribution of controlled substance analogues intended for human consumption to another distributor in Charlottesville, Virginia. These substances were designer drugs known as "bath salts," specifically methylone, MDPV, and 4-MEC, considered to be illicit analogues under the Analogue Act. On January 10, 2013, McFadden was found guilty by a jury on all counts and was sentenced to 33 months of imprisonment and 30 months of supervised release.

A motion for judgment of acquittal on the grounds that the Analogue Act was unconstitutionally vague, the court's instruction of the jury was improper, the admission of expert testimony was improper, and the evidence supporting his conviction was insufficient was denied by Chief Judge Glen E. Conrad.[3]

Appeal of judgment

McFadden appealed the lower court's judgment to the U.S. Court of Appeals for the Fourth Circuit on the grounds that the Analogue Act was unconstitutionally vague, evidentiary rulings were an improper use of the court's discretion, and that the government failed to prove the substances being distributed were controlled analogues.

The court rejected the argument that the statute was unconstitutionally vague as a person of "common intelligence" could, indeed, understand the actions prohibited by the statute, specifically the distribution of analogues "substantially similar" to those banned by the Controlled Substances Act. The court also agreed with the district court in rejecting McFadden's claim that the statutory term "human consumption" was unconstitutionally vague as it was defined by statute. The Court determined the phrase could be given an ordinary meaning. In a final determination about vagueness of the statute, the court further rejected the argument that the term "substantially similar" is impermissibly vague.

The appeals court also rejected McFadden's argument that the judge had improperly failed to instruct the jury that the government is required to prove that he had knowledge or deliberately avoided knowledge that the substances in question were controlled substance analogues covered under the Analogue Act.

Lastly, the court upheld the lower court's denial of a motion for judgment of acquittal.

The Fourth Circuit Court of Appeals upheld the district court's judgment in a unanimous opinion written by Judge Barbara Milano Keenan and joined by Chief Judge William Byrd Traxler and Judge. J. Harvie Wilkinson[4]

Petition for a writ of certiorari was granted by the Supreme Court on January 16, 2015.[5]

Judgment of the Court

In a unanimous 9–0 decision, the Supreme Court ruled that the government is required to prove that the defendant had knowledge that the substances were regulated by §841(a)(1) of the Controlled Substances Act as controlled substance analogues under the Controlled Substance Analogue Enforcement Act.

Justice Thomas wrote for the majority, joined by Justices Scalia, Kennedy, Ginsburg, Breyer, Alito, Sotomayor, and Kagan, that either knowledge that a substance is controlled without knowing the substance itself or knowledge of the substance but not that it is controlled is sufficient to satisfy the statutory requirement of intent. The opinion re-iterated that ignorance of the law is not a valid excuse.

Chief Justice Roberts concurred with the judgment and in part. He wrote in his concurring opinion that knowledge of the substance itself does not satisfy the statutory knowledge requirement. Therefore, ignorance of the law is a valid defense because the defendant could lack knowledge that the substance is controlled.[6]

The decision of the court of appeals was vacated and the case was remanded back to the Fourth Circuit to consider the jury instructions as failing to convey the Analogue Act's requirement of assessing the defendant's knowledge of the substances as controlled.[7]

See also

References

  1. ↑ 21 U.S.C. § 841(a)(1).
  2. ↑ "Title 21 United States Code Controlled Substances Act: Subchapter I". Drug Enforcement Administration. Archived from the original on April 18, 2013.
  3. ↑ United States v. McFadden, 15 F. Supp. 3d 668 (W.D. Va. 2013).
  4. ↑ United States v. McFadden, 753 F.3d 432 (4th Cir. 2014).
  5. ↑ "McFadden v. United States". SCOTUSblog.
  6. ↑ "McFadden v. United States". Oyez. Retrieved March 25, 2016.
  7. ↑ McFadden v. United States, No. 14-378, 576 U.S. ___ (2015).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.